Thiol-reactivity of the fungicide maneb  by Roede, James R. & Jones, Dean P.
Redox Biology 2 (2014) 651–655 
 
 
 
 
 
 
 
 
 
 
 
 Contents lists available at ScienceDirect 
Redox Biology 
j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / r e d o x 
Short Communication 
Thiol-reactivity of the fungicide maneb 
James R. Roede a , b , Dean P. Jones a , * 
a Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Emory University, 615 Michael Street, Atlanta, GA 30322, USA 
b Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA 
a r t i c l e i n f o 
Article history: 
Received 1 April 2014 
Received in revised form 14 April 2014 
Accepted 15 April 2014 
Keywords: 
Pesticide 
Dithiocarbamate 
Thiol 
Parkinson’s disease 
Toxicity 
a b s t r a c t 
Maneb (MB) is a manganese-containing ethylene bis-dithiocarbamate fungicide that is implicated as an
environmental risk factor for Parkinson’s disease, especially in combination with paraquat (PQ). Dithiocar-
bamates inhibit aldehyde dehydrogenases, but the relationship of this to the combined toxicity of MB + PQ
is unclear because PQ is an oxidant and MB activates Nrf2 and increases cellular GSH without apparent
oxidative stress. The present research investigated the direct reactivity of MB with protein thiols using re-
combinant thioredoxin-1 (Trx1) as a model protein. The results show that MB causes stoichiometric loss of
protein thiols, reversibly dimerizes the protein and inhibits its enzymatic activity. MB reacted at similar rates
with low-molecular weight, thiol-containing chemicals. Together, the data suggest that MB can potentiate
neurotoxicity of multiple agents by disrupting protein thiol functions in a manner analogous to that caused
by oxidative stress, but without GSH depletion. 
c © 2014 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY-NC-SA license
( http: // creativecommons.org / licenses / by-nc-sa / 3.0 / ). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Introduction 
Maneb (MB), a manganese-containing dithiocarbamate fungicide,
is used in agriculture to treat a variety of crop pathologies. Epidemi-
ological studies associate repeated human exposure to agricultural
chemicals with increased risk for Parkinson’s disease (PD) [ 1 , 2 ] and
recent reports indicate that occupational and / or residential expo-
sure to MB signiﬁcantly increases the risk of developing PD [ 3 –5 ].
Rodent models of pesticide-mediated PD show that combined effects
of paraquat (PQ) and MB exposure leads to deﬁcits in motor func-
tion, loss of tyrosine hydroxylase staining in the substantia nigra,
and altered striatal dopamine metabolism [ 6 , 7 ]. Mechanistic studies
showed that the increased toxicity of PQ + MB could be due, at least
in part, to altered toxicokinetics of PQ in mice exposed to MB [ 8 ]. 
In a recent in vitro study, we obtained evidence that MB and PQ op-
erate through divergent mechanisms of toxicity [ 9 ]. Results showed
that PQ acted via a mechanism involving reactive oxygen species
(ROS) while MB did not. MB did not increase ROS production or ox-
idize thiol-containing antioxidants (thioredoxin and peroxiredoxin),
but did activate Nrf2. Hong et al. have reported a strong correlation
between alkylation of critical Cys residues on Keap-1 and the potency
of Nrf2 activation [ 10 ]. This report and our data lead to the speculation
that MB could be a direct thiol-modifying agent causing Nrf2-Keap-1
dissociation, nuclear translocation and gene transcription. Currently,
there is no explicit evidence demonstrating that MB modiﬁes Cys* Corresponding author. 
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http://dx.doi.org/10.1016/j.redox.2014.04.007 residues, e.g. Keap-1. Therefore, the purpose of this study was to
characterize the thiol binding activity of MB utilizing N-acetylcysteine
(NAC) and thioredoxin-1 (Trx1) as model thiol containing agents. 
Materials and methods 
Materials 
Recombinant human thioredoxin-1 protein was obtained from Lab
Frontier (Korea). All other reagents were obtained from Sigma. 
Reactivity of MB with free thiols 
To investigate thiol reactivity of MB, we incubated MB (0–100 μM)
with 50 μM NAC for 15 min at 37 ◦C and measured free thiols using
Ellman’s reagent (5,5 ′ -dithiobis(2-nitrobenzoic acid) (DTNB) as de-
scribed [ 11 ]. 
Reactivity of MB with protein-bound thiols 
To assess the ability of MB to bind thiols in proteins, we utilized
Trx1 as a model protein. Brieﬂy, Trx1, in its fully reduced state [ 12 ],
was incubated with increasing concentrations of MB for 1 h at 37 ◦C.
Following MB incubation, samples were desalted using a spin column
(Pierce) and the free thiols were labeled using mPEG 2 -biotin (Pierce),
a biotinylated N-ethylmaleimide compound. The samples were then
separated via SDS-PAGE, and biotinylated protein was visualized by
Western blotting with ﬂuorescently labeled streptavidin. Reactivity
of MB to primary amines was also assessed using sulfo-NHS-biotin
(Pierce) and application of streptavidin blotting. 
 access article under the CC BY-NC-SA license ( http: // creativecommons.org / licenses / 
652 J.R. Roede, D.P. Jones / Redox Biology 2 (2014) 651–655 
Fig. 1. Maneb (MB) is a thiol-reactive compound. (A) Addition of MB to N-acetylcysteine causes loss of thiol content as measured by Ellman’s reagent. Maneb at 2:1 M ratio resulted 
in nearly complete loss of thiol. (B) Using thioredoxin-1 (Trx1) as a model protein, maneb stoichiometrically causes loss of protein thiols. Protein thiols labeled with mPEG 2 -biotin, 
a biotinylated N-ethylmaleimide, and visualized in Western blot analysis with ﬂuorescently labeled streptavidin. (C) MB does not modify amines as detected by reaction of free 
amines with sulfo-NHS-biotin and subsequent Western blot analysis with ﬂuorescently labeled streptavidin. (D) A time course demonstrates that maneb causes loss of most free 
thiols within 15–30 min. 
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To understand the functional consequences of thiol modiﬁcation 
y MB, Trx1 activity was assessed using the spectrophotometric in- 
ulin reduction assay described by Arner and Holmgren [ 13 ]. 
C–MS analysis of intact protein 
MB modiﬁcation of Trx1 was assessed using intact protein LC–MS. 
nmodiﬁed and MB-adducted Trx1 protein was analyzed using an 
ccela-LTQ Orbitrap-Velos mass spectrometer. A 10 μl injection was 
pplied to a C18 column (5 μm, 100 × 2.1 mm) and samples were 
luted using a formic acid / acetonitrile gradient. Electrospray ioniza- 
ion was used in the positive mode. Raw spectra were deconvoluted 
tilizing a procedure in the Xcaliber program (Thermo). Results 
In this report, we used N-acetylcysteine (NAC) and the thiol- 
containing redox protein, human thioredoxin-1 (Trx1), to test 
whether MB is thiol-reactive and covalently modiﬁes protein thi- 
ols. Results ( Fig. 1 A) show that free thiol concentration decreased as 
a function of MB concentration with a complete loss when MB:NAC 
reached 2:1. A kinetic assay showed that the apparent 2nd order rate 
constant was 5.03 M −1 s −1 (data not shown). We next examined the 
reactivity of MB with protein thiol using recombinant Trx1 as a model. 
This protein contains thiol residues that are solvent accessible, have 
a spectrum of reactivity and are essential for its biological function 
[ 12 ]. Fig. 1 B shows a stoichiometric loss of protein thiols due to MB 
treatment. Trx1 contains 5 Cys residues and the biotin signal was 
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Fig. 2. Maneb inhibits thioredoxin-1 (Trx1) activity. Trx1 was treated with 5 M equivalents of maneb and activity was measured in terms of insulin reduction in the presence of 
NADPH and thioredoxin reductase-1. Decreased activity was evident in the rate of NADPH oxidation (A) and the calculated activity (B). Assay with DTT as the reductant instead of 
the NADPH / thioredoxin reductase did not show inhibition of activity (not shown). Loss of protein thiols is associated with formation of a Trx1 dimer and reversed by addition of a 
reductant. Both the reductant DTT (C) and N-acetyl cysteine (D) can reverse maneb-mediated loss of protein thiols. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 lost when incubated with MB:Trx1 at a molar ratio of 5:1, indicat-
ing complete modiﬁcation of thiols (either adduction or oxidation,
see below). Reactivity of MB to primary amines was also investigated
( Fig. 1 C) using a procedure that is similar to visualizing protein thiols.
Following MB incubation, the free amines were labeled and visual-
ized using sulfo-NHS-biotin as demonstrated in Fig. 1 B. These results
show that MB does not react with amines under the conditions of
the assay, preferentially modifying only protein thiols. The kinetics of
the reaction was investigated with 5:1 concentration ratio using the
mPEG 2 -biotin method ( Fig. 1 D). In agreement with the NAC reactiv-
ity data, results from this experiment show that the reaction between
MB and Trx1 is relatively slow, approaching complete modiﬁcation of
all Trx1 thiols at 60 min. 
The activity of Trx1 was assessed to determine functional conse-
quences of MB adduction. Trx1 was incubated for 1 h with MB (5:1,
as above) and then desalted to remove any unreacted MB prior to the
activity assay. Data show that MB modiﬁcation of Trx1 slowed the
Trx1-dependent oxidation of NADPH in the presence of Trx reductase
by 43% ( Fig. 2 A and B). In contrast to these results, Trx1-catalyzed
insulin reduction by DTT showed no effect on activity due to MB
modiﬁcation (data not shown). The incomplete inhibition of activity
despite evidence for nearly complete modiﬁcation of thiols indicated
that MB-dependent thiol modiﬁcation is likely to be reversible. 
To examine reversibility, MB-modiﬁed Trx1 was incubated with
1 mM DTT, and thiol content was examined with mPEG 2 -biotinylation
and Western blotting as above. Results showed that the band corre-
sponding to the unmodiﬁed thiol form of Trx1 was restored ( Fig. 2 C).
Titration with NAC (increasing the ratio of NAC:MB from 0 to 13.3)
showed that greater than a 5-fold excess of NAC was required to
restore all of the thiols ( Fig. 2 D). The results, therefore, show that
modiﬁcation of Trx1 by MB is completely reversible by treatment
with thiols. 
X-Ray crystallography showed that oxidized Trx1 is crystalized as
a dimer formed by a disulﬁde between C73 residues [ 14 ]. We inves-
tigated the possibility that MB treatment caused formation of a Trx1
dimer by treating Trx1 with increasing concentrations of MB, separa-
tion via SDS-PAGE under non-reducing conditions and visualization
with Coomassie blue ( Fig. 3 A). The data demonstrate that MB results in appearance of a band at 25 kD, corresponding to twice the molec-
ular weight of Trx1, with as little as 1 M equivalent of MB. This result
indicates that only one Cys residue is involved in the dimerization. 
Due to the observation of MB-mediated protein cross-linking, we
conducted LC–MS studies of intact, MB-treated Trx1 using ESI in the
positive ionization mode and detection with an LTQ-Orbitrap-Velos
(Thermo). These experiments resulted in the detection of Trx1 and a
single modiﬁed product ( Fig. 3 B and C). In the MB-modiﬁed sample,
we observed a large decrease in intensity of the unmodiﬁed Trx1 peak
( m / z 11,602) and a new peak ( m / z 11,810) caused by the binding
of ethylene bis-dithiocarbamate (EBDTC) to Trx1, resulting in a mass
shift of 210 mass units from the unmodiﬁed peak. This result suggests
that MB does not cause a simple oxidation of thiols to disulﬁdes but
rather participates in more complex reaction processes. 
Discussion 
In this study we demonstrated the thiol reactivity of the dithio-
carbamate fungicide MB. The data show that MB is a thiol-reactive
substance that causes dimerization of Trx1 in vitro but do not dis-
criminate between oxidation and more complex cross-linking that
could occur through the two dithiocarbamate moieties in MB. Mod-
iﬁcation resulted in a partial inhibition of Trx1 activity, indicating
that MB is either modifying active site thiol residues or peripheral
residues, such as C73, that result in decreased activity. It should be
emphasized again that Trx1 was employed as a model protein for
these studies. Trx1 possesses thiol residues that are solvent accessi-
ble, have a spectrum of reactivity and are essential for its biological
function [ 12 ]. 
Our data also demonstrate that the reaction between MB and thi-
ols is relatively slow, with a rate constant (5.03 M −1 s −1 ) similar to
that for reaction of H 2 O 2 and Trx1 (1.05 M 
−1 s −1 ) and thiol–disulﬁde
exchange (20 M −1 s −1 ) [ 15 , 16 ]. Previous data show that NAC pre-
treatment can protect against MB-induced injury in Chinese hamster
V79 cells, indicating that increased cellular thiols can protect or even
prevent toxicity associated with an acute MB exposure [ 17 ]. With
this in mind, the present data indicate that relatively slow, reversible
binding of MB with protein thiols could trap MB in cells. Because pro-
tein thiols involved in redox signaling are more reactive than other
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Fig. 3. MB treatment causes Trx1 to form a dimer that is reversed by DTT (A). Mass spectral analysis of intact Trx1 (B) and MB-modiﬁed Trx1 shows (C) a single MB modiﬁcation 
(addition of 210 mass units corresponding to the addition of the ethylene bis-dithiocarbamate (EBDTC)). The asterisk (*) denotes an m / z corresponding to a potential Mn-Trx1 
adduct ( + 54.9). 
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Nellular thiols, such retention could allow transfer to more reactive 
hiols and cause prolonged disruption of redox circuits that function 
n redox signaling and control [ 18 , 19 ]. 
Consequently, the data suggest that MB and other similar dithio- 
arbamates, including mancozeb, disulﬁram and zineb [ 20 –22 ], may 
ause toxicity by disruption of redox circuits that function in cellular 
omeostasis. Perhaps more importantly, such interaction with critical 
edox signaling systems could potentiate neurotoxicity by interfering 
ith essential cell stress response mechanisms. Although speculative, 
uch a mechanism could explain the combined toxicity of MB and PQ 
n PD. 
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